Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for $1.8 billion, expanding further into the field of heart and kidney drugs.
from Medical Xpress - latest medical and health news stories https://ift.tt/a62xMjU
